Randomised controlled trial of the Community Navigator programme to reduce loneliness and depression for adults with treatment-resistant depression in secondary community mental health services: trial protocol

被引:2
|
作者
Stefanidou, Theodora [1 ]
Ambler, Gareth [2 ,3 ]
Bartl, Gergely [1 ]
Barber, Nick [1 ,4 ]
Billings, Jo [1 ]
Bogatsu, Tumelo [5 ]
Carroll, Richard [6 ]
Chipp, Beverley [1 ,4 ]
Conneely, Maev [1 ]
Downey, Anne-Marie [3 ]
Evlat, Gamze [1 ,7 ]
Hunter, Rachael [3 ,8 ]
Le Novere, Marie [3 ,8 ]
Lewis, Glyn [1 ,3 ,7 ]
Mackay, Tanya [4 ]
Marwaha, Steven [5 ]
Matin, Zubair [1 ]
Naughton, Georgia [4 ]
Nekitsing, Chandani [9 ]
O'Sullivan, Millie [1 ,7 ]
Pinfold, Vanessa [4 ]
Pan, Shengning [2 ,3 ]
Sobers, Angela [10 ]
Thompson, Keith J. [4 ,6 ]
Vasikaran, Jerusaa [1 ]
Webber, Martin [9 ]
Johnson, Sonia [1 ,7 ]
Lloyd-Evans, Brynmor [1 ]
机构
[1] UCL, Div Psychiat, Maple House,149 Tottenham Court Rd, London W1T 7NF, England
[2] UCL, Dept Stat Sci, London, England
[3] UCL, Priment Clin Trials Unit, London, England
[4] McPin Fdn, London, England
[5] Univ Birmingham, Inst Mental Hlth, Birmingham, England
[6] NHS Fdn Trust, Tees Esk & Wear Valley, Durham, England
[7] Camden & Islington NHS Fdn Trust, London, England
[8] UCL, Dept Primary Care & Populat Hlth, London, England
[9] Univ York, Sch Business & Soc, York, England
[10] NHS Mental Hlth Trust, Barnet Enfield & Haringey, London, England
关键词
Loneliness; Depression; Community navigator; Randomised controlled trial; STAR-ASTERISK-D; LONG-TERM; SCALE; CARE; DISORDER; VALIDITY; OUTCOMES; ANXIETY; PEOPLE; PHQ-9;
D O I
10.1186/s13063-023-07684-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundNew treatments are needed for people with treatment-resistant depression (TRD), who do not benefit from anti-depressants and many of whom do not recover fully with psychological treatments. The Community Navigator programme was co-produced with service users and practitioners. It is a novel social intervention which aims to reduce loneliness and thus improve health outcomes for people with TRD. Participants receive up to 10 individual meetings with a Community Navigator, who helps them to map their social world and set and enact goals to enhance their social connections and reduce loneliness. Participants may also access group meet-ups with others in the programme every 2 months, and may be offered modest financial support to enable activities to support social connections.MethodsA researcher-blind, multi-site, 1:1 randomised controlled trial with N = 306 participants will test the effectiveness of the Community Navigator programme for people with TRD in secondary community mental health teams (CMHTs). Our primary hypothesis is that people who are offered the Community Navigator programme as an addition to usual CMHT care will be less depressed, assessed using the PHQ-9 self-report measure, at 8-month, end-of-treatment follow-up, compared to a control group receiving usual CMHT care and a booklet with information about local social groups and activities. We will follow participants up at end-of-treatment and at 14 months, 6 months after end-of-treatment follow-up. Secondary outcomes include the following: loneliness, anxiety, personal recovery, self-efficacy, social network, social identities. We will collect data about health-related quality of life and service use to investigate the cost-effectiveness of the Community Navigator programme.DiscussionThis trial will provide definitive evidence about the effectiveness and cost-effectiveness of the Community Navigator programme and whether it can be recommended for use in practice. The trial is due to finish in August 2025.Trial registrationProspectively registered on 8th July 2022 at: ISRCTN13205972.
引用
收藏
页数:15
相关论文
共 50 条
  • [11] Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial
    Tallon, Debbie
    Wiles, Nicola
    Campbell, John
    Chew-Graham, Carolyn
    Dickens, Chris
    Macleod, Una
    Peters, Tim J.
    Lewis, Glyn
    Anderson, Ian M.
    Gilbody, Simon
    Hollingworth, William
    Davies, Simon
    Kessler, David
    TRIALS, 2016, 17
  • [12] Evaluating the efficacy and mechanisms of a ketogenic diet as adjunctive treatment for people with treatment-resistant depression: A protocol for a randomised controlled trial
    Gao, Min
    Kirk, Megan
    Lash, Eva
    Knight, Heather
    Michalopoulou, Moscho
    Guess, Nicola
    Browning, Michael
    Weich, Scott
    Burnet, Philip
    Jebb, Susan A.
    Stevens, Richard
    Aveyard, Paul
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 174 : 230 - 236
  • [13] Collaborative community mental health and aged care services with peer support to prevent late-life depression: study protocol for a non-randomised controlled trial
    Liu, Tianyin
    Leung, Dara Kiu Yi
    Lu, Shiyu
    Kwok, Wai-Wai
    Sze, Lesley Cai Yin
    Tse, Samson Shu Ki
    Ng, Siu Man
    Wong, Paul Wai Ching
    Lou, Vivian Wei Qun
    Tang, Jennifer Yee Man
    Wong, Daniel Fu Keung
    Chan, Wai Chi
    Kwok, Ricky Yu Kwong
    Lum, Terry Yat Sang
    Wong, Gloria Hoi Yan
    TRIALS, 2022, 23 (01)
  • [14] Cognitive behavior therapy for older adults with insomnia and depression: a randomized controlled trial in community mental health services
    Sadler, Paul
    McLaren, Suzanne
    Klein, Britt
    Harvey, Jack
    Jenkins, Megan
    SLEEP, 2018, 41 (08)
  • [15] Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial
    Husain, Muhammad I.
    Chaudhry, Imran B.
    Khoso, Ameer B.
    Husain, Mohammad Omair
    Rahman, Raza R.
    Hamirani, Munir M.
    Hodsoll, John
    Carvalho, Andre F.
    Husain, Nusrat
    Young, Allan H.
    BJPSYCH OPEN, 2019, 5 (01):
  • [16] The Neurostimulation of the Brain in Depression Trial: Protocol for a Randomized Controlled Trial of Transcranial Direct Current Stimulation in Treatment-Resistant Depression
    Suleman, Raheem
    Tucker, Benjamin, V
    Dursun, Serdar M.
    Demas, Michael L.
    JMIR RESEARCH PROTOCOLS, 2021, 10 (03):
  • [17] Effectiveness of blended depression treatment for adults in specialised mental healthcare: study protocol for a randomised controlled trial
    L. L. Kemmeren
    D. J. F. van Schaik
    H. Riper
    A. M. Kleiboer
    J. E. Bosmans
    J. H. Smit
    BMC Psychiatry, 16
  • [18] BEAT-IT: Comparing a behavioural activation treatment for depression in adults with intellectual disabilities with an attention control: study protocol for a randomised controlled trial
    Jahoda, Andrew
    Melville, Craig
    Cooper, Sally-Ann
    Hastings, Richard
    Briggs, Andrew
    Dagnan, Dave
    Hatton, Chris
    McConnachie, Alex
    Williams, Chris
    Jones, Robert S. P.
    TRIALS, 2015, 16
  • [19] The postcard intervention against depression among community-dwelling older adults: study protocol for a randomized controlled trial
    Imai, Hissei
    Furukawa, Toshiaki A.
    Okumiya, Kiyohito
    Wada, Taizo
    Fukutomi, Eriko
    Sakamoto, Ryota
    Fujisawa, Michiko
    Ishimoto, Yasuko
    Kimura, Yumi
    Chen, Wen-ling
    Tanaka, Mire
    Matsubayashi, Kozo
    TRIALS, 2013, 14
  • [20] Navigator programme for hospitalised adults experiencing homelessness: protocol for a pragmatic randomised controlled trial
    Liu, Michael
    Pridham, Katherine Francombe
    Jenkinson, Jesse
    Nisenbaum, Rosane
    Richard, Lucie
    Pedersen, Cheryl
    Brown, Rebecca
    Virani, Sareeha
    Ellerington, Fred
    Ranieri, Alyssa
    Dada, Oluwagbenga
    To, Matthew
    Fabreau, Gabriel
    McBrien, Kerry
    Stergiopoulos, Vicky
    Palepu, Anita
    Hwang, Stephen
    BMJ OPEN, 2022, 12 (12):